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Eosinophils play an important role in host defense 
against parasitic infection, employing both oxidative and 
nonoxidative systems to effect damage. The active oxy-
gen product, hydrogen peroxide, either alone or in com-
bination with the enzyme eosinophil peroxidase, may 
damage parasites. These studies use a sensitive fluoro-
metric assay to document the release of hydrogen per-
oxide from guinea pig peritoneal exudate eosinophils 
and human peripheral blood eosinophils. Guinea pig 
eosinophils released 0.13 ± 0.02 (n = 10) nmol H 20z/105 
eos/5 min under resting conditions which were mark-
edly increased when stimulated by phorbal myristate 
acetate (PMA, 1 p.g/ml) [ 4.80 ± 0.50 (19) nmol H zOz/105 
eos/5 min], preopsonized zymosan [2.40 ± 0.17 (4) nmol 
HzOz/105 eos/5 min], or latex beads [1.14 ± 0.26 (5) nmol 
H202!105 eos/5 min). Normal human peripheral blood 
eosinophils had greater resting release of hydrogen per-
oxide [0.34 ± 0.05 (8) nmol H20z/10" eos/5 min], but were 
less effectively stimula,ted by PMA [3.12 ± 0.57 (9) nmol 
H202!105 eos/5 min], preopsonized zymosan [0.78 ± 0.16 
(8) nmol H~Oz/10" eos/5 min] or latex beads [0.69 ± 0.32 
(6) nmol HzOz/105 eos] (p s 0.05). Hydrogen peroxide 
release was markedly enhanced by the presence of ex-
ogenous glucose and was linearly dependent upon cell 
number when the soluble stimulus PMA was used. Par-
ticle-stimulated hydrogen peroxide was not necessarily 
enhanced by increases in the particle:cell ratio. The 
demonstration of the release of large amounts of hydro-
gen peroxide from eosinophils is further support for the 
concept that eosinophils play an active role in host de-
fune. ' 
Eosinophils play a crucial role in host defense against para-
sit ic infection [1]. Depletion of eosinophils by the use of anti-
eosinophil serum increases the number of eggs produced in 
experimental schistosomiasis [2]. In vitro studies have demon-
strated eosinophil-mediated destruction of both schistosomula 
of Schistosoma mansoni and newborn larvae of Trichinella 
spiralis [3,4]. The active oxygen product, hyc:b-ogen peroxide, 
alone or in combination with t~e enzyme eosinophil peroxidase, 
forms a potent antimicrobial system which may be one of the 
mechanisms by which eosinophils damage parasites; however, 
nonoxida tive mechanisms may also be involved [5-8]. Studies 
of hydrogen peroxide production by eosinophils have used the 
less accurate method of formate oxidation for quantitation of 
hydrogen peroxide release [9]. This method has several disad-
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vantages. It is relatively insensitive; formate can decay sponta-
neously leading to high background levels of spontaneous 14C02 
release; exogenous catalase is necessary to enhance the rate of 
detection. Little is known about the factors that regulate h y-
drogen peroxide production by eosinophils. We have studied 
the release of hyd1·ogen peroxide from both guinea pig perito-
neal exudate eosinophils a nd human peripheral blood eosino-
phils. Our studies demonstrate that large amounts of hydrogen 
peroxide are released following stimulation of eosinophils and 
further characterize the conditions optimal for its release. 
MATERIALS AND METHODS 
Leukocyte Suspensions 
Guinea pig peri toneal exuda te eosinophils were harvested from pol-
ymyxin B-treated guinea pigs according to our previously described 
method [10]. Briefly, an ima ls received 1 mg of polymyxin B in traperi-
toneally on a weekly basis. Twenty-four hours late r the eosinophils 
were harvested by saLine lavage. Guinea pig eosinophils were purified 
to grea ter than 98% purity on discontinuous metrizamide gradients . 
Fractions were pooled, counted, and washed as previously described 
[11]. Human eosinophils were prepared from normal a nd hypereosi-
nophilic patients as described [12]. Briefly, dextran-sedimented leuko-
cyte-conta ining plasma was layered on discontinuous metrizamide gra-
dients. Eosinophils were harvested from the 24%/25% in terface or from 
the pellet. Contaminating erythrocytes were removed by hypotonic 
lysis. Suspensions usually contained greater than 85% eosinophils for 
human studies, the contaminating cells being neutrophils. 
Measurement of Hydrogen Peroxide Production 
H ydrogen peroxide was measured by the spectrofluorometric method 
of Root et al employing scopole tin [13). Brie fly, eosinophils were added 
to cuvettes conta ining 10 nmol of scopole tin and 30 uni ts of horseradish 
peroxidase (Sigma Chemical Co. St. Louis, MissoUl'i) in Hanks' bal-
anced salt solu t ion (HBSS) or Krebs-Ringer phosphate (KH.P) buffer, 
pH 7.4. The amount of hydrogen peroxide gene1·a ted was determined 
by preparing a standard curve using ethyl hydrogen peroxide (Polysci-
ences, Inc., Wanington, Pennsylvania) . Eosinophils suspended in either 
phosphate-buffered saline (PBS) or HBSS were added to cuvettes, final 
volume 1.0 cc. The incubation mixture was continuously stirred within 
the cuvette using a magnetic stiJTing device. The cells were allowed to 
eq uilibrate for 2 min prior to the addition of stimulus. Stimuli employed 
included phorbol myrista te acetate (PMA) (l fLg/ml , S igma Chemical 
Co.), latex particles (1.1 fllll diameter, Dow Chemical Company, Mid-
lands, Michigan) , and preopsonized zymosan, prepared as previously 
described [9]. Other items were obta ined as follows: cytochalasin b 
(Sigma Chemical Co.) and glucose (Fisher Chemical Co.). The decrease 
in flu orescence was measured in the linear portion of the curve over 
the initia l S min. Resting hydrogen peroxide determinations were based 
on a 4- or 5-min eq uilibration prior to the addition of stimulus. Results 
are expressed as nanomoles of hydrogen peroxide produced per 10" 
eosinophils per 5-min period unless otherwise noted. Each experimental 
value represents the average of duplicate determinations obtained on 
the same ce ll suspension. All experiments were perform ed on 2 or more 
differen t cell suspensions on different days. Results of more than 2 
experiments are expressed as the mean plus or minus the standard 
error of the mean. 
RESULTS 
Initial studies of guinea pig eosinophils were designed to 
optimize the conditions for measw·ement of hydrogen peroxide 
(Tables I, II) using the spectrofluorometric method. Standard 
conditions were determined using pmified guinea pig peritoneal 
exudate eosinophils suspended in calcium-free KRP containing 
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TABLE I. Hydrogen p eroxide release by eosinopitils 
Guinea pig eosinophils 
Human eosinophils 
Normal 
Hypereosinophil ic 
Resting 
0.13 ± 0.02 (10) 
0.34 ± 0.05 (8). 
0.20 ± 0.00 (2) 
PMA 
4.80 ± 0.50 (19) 
3.12 ± 0.57 (9)* 
5.10 ± 0.71 (2) 
Stim ulated 
(nmols H ,0 ,/10'' eos/ 5 min) 
Zymosan Latex 
2.40 ± 0.17 (4) 1.14 ± 0.26 (5) 
0.78 ± 0.16 (8)* 0.69 ± 0.32 (6) 
Eosinophils wc1·c allowed to equilibrate for 2- 4 min prio1· to the addi tion of stimulus. For resting and PMA studies, I X 10'' eosinophils 
suspended in HBSS were employed. For particulate stimuli, 5 X 10'' eosinophils were employed with 0.02 cc of latex beads or 0.02 mg of 
preopsonized zymosan. The particle:cell ratios were 2000:1 for latex and 200:1 for zymosan. Star indicates p ::s 0.05 for the significan ce of the 
difference between human and guinea pig eosinophils; p values were ::S 0.05 for the difference between PMA and latex or zymosan stimula ted 
eosinophils . Only those experiments employing HBSS a re included in this tab le; and the number of experiments performed in duplicate is 
indicated in parentheses. 
TABLE II. Enhancement of hydrogen peroxide release by the addition of glucose 
Glucose 
KRP HBSS 
+ 0. 1 mM + 1 mM + 10 mM 
3.25 ± 1.08 6.9 ± 0.56 8.9 ± 1.16 8.2 ± 0.57 7.1 ± 0.58 nmol H"Od lO'' eos/ 5 min 
100% 209 ± 68.0 282 ± 65.4 255 ± 63.8 298 ± 59.0 % control 
Guinea pig eosinoph ils (I x 10") were incubated in KRP wi th or without glucose or in HBSS. Hydrogen peroxide production was activated by 
t he addi tion of PMA (1/-'g/ ml) . Resu lts are expressed as nmol H 20 2/ 10'' eosinophils for a 4-min period and as % of the KRP control. Results are 
the mean of 3-6 experiments performed in duplicate. Only those experiments specifica lly designed to study the effects of t he addition of glucose 
are included in th is tab le. 
10 nmol of scopoletin and 30 U of horseradish peroxidase. In 
the absence of a stimulus, minimal hydrogen peroxide release 
was detected. When purified guinea pig eosinophils were em-
ployed under resting conditions~ little hydrogen peroxide release 
was detected (0.73 ± 0.02 nmol/105 eos/5 min). An almost 40-
fold increase was observed following the add ition of the soluble 
stimulus PMA (1 !Lg/ ml) (4.80 ± 0.50 nmol/10" eos). When 
PMA was the stimulus, the amount of hydrogen peroxide 
detected was dependent upon the cell number employed (Fig 
1) . For most experiments 1 X 10" eosinophils were employed. 
More ceiJs were necessary when particulate stimuli were em-
ployed since the small amounts of hydrogen peroxide made 
detection difficult. 
Though initial studies were performed us ing KRP, the addi-
tion of glucose m· t he substitution of glucose-containing HESS 
markedly enhanced the hydrogen peroxide release foiJowing 
stimulation by PMA (Table II). All subsequent experimen.ts 
were performed with HESS. The addition of calcium to KRP 
in the presence or absence of glucose did not increase the 
amount of hydrogen peroxide detected (data not shown) . 
Several other factors were important in the measurement of 
hydrogen peroxide production. Zymosan without preopsoniza-
tion by serum failed to stimulate hydrqgen peroxide production. 
When serum was added to the reaction mixture along with the 
zymosan, the presence of serum interfered with the measure-
ment of hydrogen peroxide (10]. The addition of bovine serum 
albumin (0.1mg/ml) similarly interfered with assay of hydrogen 
peroxide (data no t shown). Thus all experiments were per-
formed in the a bsence of exogenous protein. The concentrations 
of PMA employed in these experiments were chosen on the 
basis of previous experiments studying superoxide anion pro-
duction. Doubling the concentration did not enhance the hy-
drogen peroxid e detected (data not shown) . Finally, constant 
mixing of the reaction mixture using our magnetic stirring 
device was essentia l for optimal detection of hydrogen peroxide. 
Less than ha lf the amount of hydrogen peroxide was detected 
in the absence of stirring. 
Use of Particulate Stimuli 
Particula te stimuli, preopsonized zymosan and latex beads 
were less effective stimuli than PMA (Table I). Indeed, in order 
to reliably measure hydrogen peroxide production, 5 t imes the 
number of cells we1·e required. Using preopsonized zymosan as 
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FI G 1. Guinea pig peri toneal exudate eos inophils suspended in KHP 
were added in the indicated numbers and hydrogen peroxide measured 
following the add ition of 1 fLg/ ml of PMA. Results are t he mean ± SEM 
of 2 experiments, each performed in duplicate. 
the stimulus, 2.4 ± 0.7 nmol H,0~/ 10'' eos/ 5 min were released. 
Latex beads stimulated the release of only about one-half the 
amount of hydrogen peroxide (1.14 ± 0.26 nmol / 10'' eos/ 5 min) . 
Table I includes only those results obtained using HESS as the 
buffer. Similar results were obtained using KRP, though the 
absolute amount of hydrogen peroxide was r educed. Standard 
particle:ceiJ ratios shown in the figures and tables were 2000:1 
for latex, 200:1 for zymosan, and employed 5 x 10'' guinea pig 
or human eosinophils. When the particle:ceiJ ratio was main-
tained, a 5-fold increase in the number of cells resulted in only 
a 2-fold increase in the detectable hydrogen peroxide. Increasing 
the concentration of scopoletin or the amount _of horseradish 
peroxidase did not increase detectable hydrogen peroxide under 
these condi t ions; thus scopoletin was not a limiting factor. 
Increasing the particle:ceU ratio did not increase the hydrogen 
peroxide detected (Table III). When latex beads were the 
particle tested, a 20-fold increase in the number of beads 
resulted in a marked decrease in the detectable hydrogen 
peroxide (Table III) . When preopsonized zymosan was tested, 
\10 increase in detectable hydrogen peroxide was noted when 
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TABLE III. Variation in hydrogen p eroxide release with changes in 
the particle:cell ratio 
Particle Particle:cell ratio 
Latex beads 20,000:1 
0.80 (nmol H ,0 ,/10'' eos) 
500:1 1,000:1 Preopson-
ized zym-
1,000:1 
1.40 
20: 1 
0.40 
2,000:1 
1.60 
100:1 
1.20 
10,000:1 
0.70 
200:1 
4.20 4.00 5.40 (nmol H , 0 ,/10'' eos) 
osan 
Guir.ea pig eosinophils (1 x 105 ) were incubated with e ither preopsonized 
zymosan or latex beads at the indicated particle: cell ratios and hyd rogen perox ide 
release measured. Neither latex beads nor preopsonized zymosan at the indicated 
concentrations interfe red with measurement of hydrogen peroxide using an ethyl 
hydrogen peroxide s tandard. The resul ts are the mean of2 experiments performed 
in duplicate, each employing cells suspended in HBSS. S imila r resu lts were 
obLained in KRP; however these results a re not included in the table. 
TABLE IV. Effect of cyto bon oxidative metabolism 
Stimu lated (% control) 
Eosinophil Resting P reopson-function ized Latex PMA 
zymosan 
Hydrogen perox- 100 ± 0 50.0 ± 20.8 116.0 ± 12. 10 (a) N.D. 
ide production 95.0 ± 31.2 (b) 
Superoxide anion 126.6 ± 28.0 45.1 ± 14.5 N.D. 41.4 ± 2.0 
production 
Quantitative leu- 114.8 ± 43.1 34.4 ± 12.4 N.D. N.D. 
kocyte iod ina-
tion 
Guinea pig eosinoph ils suspended at t he approp riate concentration were prein-
cubated with 5 Mimi of cyto b at room tem peratu re for 5 min prior to the 
add it ion of stimulus and the init iation of the assay. Incubations were performed 
in duplicate according to t he standru·d method as described in Materials and 
Methods. 
Results repr~se n t the mean of 2-4 experiments and a re expressed as % of the 
untreated control. N.D. denotes experiment was not performed. Particle:cell ratios 
for the hydrogen perox ide assay were 200:1 for preopsonized zymosan, and either 
1000:1 [indicated by (a)] or 20,000:1 [( indica ted by (b)] for latex beads. 
the particle:cell ratio was increased above the standard 200:1 
ratio. Below this ratio, hydrogen peroxide release was linearly 
related to t he number of particles. Though these experiments 
illustrate resul ts obtained with guinea pig eosinophils, similar 
results were obtained with human eosinophils. 
Since failure to detect hydrogen' peroxide might result from 
trapping within the phagocytic vacuole when engulfable partic-
ulate stimuli (latex beads or preopsonized zymosan) were em-
ployed, cytochalasin b (cyto b) was added to prevent fusion of 
the phagocytic vacuole (Table IV) [13]. However, no enhance-
ment of hydrogen peroxide production was noted studying 
particulate stimuli and guinea pig eosinophils. This was tested 
at different particle:cell ratios, using both latex beads and 
preopsonized zymosan. In other experiments (not shown), in-
creasing the number of eosinophils to 10'; did not detect en-
hancement of hydrogen peroxide in the presence of cyto b. 
Under these conditions cyto b did not inhibit phagocytosis of 
preopsonized zymosan by guinea pig eosinophils, as judged by 
a morphologic assay. Cyto b did, however, h ave addit ional 
effects on the oxidative metabolism of eosinophils (Table IV) . 
Both superoxide anion production a nd quantitative leukocyte 
iodination were reduced in the presence of cyto b. This was 
observed using both preopsor~ized zymosan a nd PMA as the 
stimulus. Human eosinophils were similarly inhibited when 
superoxide production was measured in the presence of cyto b. 
Resting levels for all oxidative functions were so low that it was 
difficult to reliably measure ch a nges. In sum, these studies 
suggest that cyto b inhibits th e oxidative metabolism of eosin-
ophils, and as such is not useful in studies of hydrogen peroxide 
production. 
Studies Employing Hu.man Eosinophils 
Human eosinophils purified from peripheral blood by discon-
tinuous metrizamide gradien ts were studied using the tech-
niques t hat had been developed for th e study of guinea pig 
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eosinophils. All studies were performed using HBSS containing 
glucose since preliminary experiments demonstrated that cells 
suspended in KRP released less hydrogen peroxide. There were 
several importa'nt differences. In contrast to guinea pig eosino-
phils, there was greater production of hydTogen peroxide by 
unstimu lated (resting) eosinophils (Table 1) . The addition of 
PMA markedly increased detectable hydrogen peroxide, but to 
levels lesser th an guinea pig eosinophils. Human eosinophils 
produced significantly less hydrogen peroxide (p ::S 0.05) when 
stimulated by preopsonized zy mosan, but were equivalent to 
guinea pig cells when latex beads were employed as the stimu-
lus. Eosinophils fi·om 2 patients with hypereosinophilia related 
to eosinophilic gastroenteritis were studied under resting (0.20 
± 0.0002 nmol H 20 z/10'' eos/5 min) and PMA-stimulated con-
ditions (5.10 ± 0.71 nmol H 20z/105 eos/5 min) . 
DISCUSSION 
Hydrogen peroxide is a key active oxygen product involved 
in host defense and infla mmation [6]. These studies accurately 
quantitate and characterize hydrogen peroxide release by hu-
man and guinea pig eosinophils and document similar unique 
features. Of special interest is a marked requirement for exog-
enous glucose. This suggests that the energy sources for r elease 
of hydrogen peroxide requiJ·e a continuous supply of glucose or 
are quickly depleted. Furthermore, this requirement, which has 
been noted a lso in macrophages, may limit the conditions under 
which eosinophils can participate in host defense (14]. 
The second unusual feature of hydrogen peroxide release by 
eosinophils is the lack of enhancement by the addition of cyto 
b. In neutrophils the addition of cyto b enhances superoxide 
anion and hydrogen peroxide release, presumably by interfering 
with fusion of the phagocytic vacuole while at the same time 
inhibiting oxygen consumption [15]. In our studies we have also 
demonstrated inhibition of superoxide production by eosino-
phils treated with cyto b. Thus t he failme to note enhanced 
hydrogen peroxide production could also be due to inhibi t ion 
of oxygen uptake as well as a lack of effect on phagocytosis. 
The inhibition of iodination may similarly represent a decrease 
in oxygen uptake and a consequent decrease in hydrogen per-
oxide necessary for iodination to occur. Cyto b also has differ-
ential effects on release of granular enzymes from eosinophils 
a nd neutrophils [16], a nd thus differential effects on oxidative 
metabolism are not unexpected . Because of the variety of effects 
on eosinophils, cyto b is not useful for studying th e site of origin 
of hydrogen peroxide production. 
Wit h bot h human and guinea pig eosinophils, particulate 
stimuli are much less effective stimuli than PMA. The failme 
to detect more hydrogen peroxide after increases in the parti-
cle:cell ratio differs from observations concerning neutrophils. 
Root et al noted linearity with latex beads only at particle:cell 
ratios from 400:1 to 1200:1 and not at higher particle:cell ratio 
[13]. Our previous studies of eosinophils using formate oxidation 
to measure hydrogen peroxide similarly noted a n absence of 
linearity as did studies of hexose monophosphate shunt acti-
vation, stimulated by latex particles (9]. When preopsonized 
zymosan was the stimulus tested at particle:cell ratios below 
200:1 linearity was noted. Eosinophils thus appear to have a 
limited abili ty to increase the oxidative metabolism above a 
certain level. However, there are other possible explanations. 
Hydrogen peroxide may be trapped within the phagocytic vac-
uole and thus not accessible to the extracellular scopoletin 
assay system. Another possible explanation is that sites on the 
particle compete with scopoletin and react with hydrogen per -
oxide, thus reducing the m easurable hydrogen peroxide. It m ay 
also be that the constant mixing in our system changes the 
ch aracteristics of the reaction. 
In addition to these unique similarities between human and 
guinea pig eosinophils, there are differences which may reflect 
theiJ· varying origins (peripheral blood vs. peritoneal exudate) 
or species differences. It is unlikely that polymyxin B treatment 
is responsible because our previous studies h ave shown that 
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peritoneal exudate eosinophils harvested from polymyxin B-
treated guinea pigs are similar to those harvested from un-
treated animals [9]. Certain differences are noteworthy. Firstly, 
guinea pig eosinophils had a lower resting production of hydro-
gen peroxide, which is not due to decreased oxidative metabo-
lism since stimulated guinea pig eosinophils had more active 
oxidative metabolism. Increased resting hydrogen peroxide 
release by human eosinophils could represent modification of 
peripheral blood eosinophils by circulating factors [17]. Alter-
natively, the site of hydrogen peroxide release in human eosin-
ophils may be more accessible to measurement by our extra-
cellular assay system. Stimulated guinea pig eosinophils appear 
to release more hydrogen peroxide than human eosinophils; 
this may represent more active oxidative metabolism or a more 
accessible site of production. The greater amount of hydrogen 
peroxide release following stimulation by preopsonized zymosan 
may reflect differences in the numbers of C3b receptors present 
on human and guinea pig eosinophils. 
Previous studies of eosinophils have focused on quantitative 
differences between eosinophils and neutrophils [16-18]. Eosin-
ophils, usually obtained from hypereosinophilic patients, were 
more active than neutrophils [18-20]. Preliminary studies in 
om la boratory note few quantitative differences between eosin-
ophils and neutrophils. An important quantitative difference is 
that eosinophils do produce small amounts of hydrogen perox-
ide under resting conditions, whereas neutrophils have essen-
tially no detectable hydrogen per.oxide production. Eosinophils 
produce approximately 10-fold more hydrogen peroxide than 
activated peritoneal exudate macrophages, which have a rela-
tively low level of oxidative metabolism [14,20]; this difference 
is more than would be expected on the basis of laboratory 
variation. 
Differences in hydrogen peroxide release between eosinophils 
from normal persons and patients with hypereosinophilic syn-
drome were observed, consistent with our observations that 
metabolic heterogeniety exists among human eosinophils [12]. 
Unfortunately the small number of patients available for study 
make it difficul t to draw any conclusions. They do suggest that 
a worthwhile question is whether elevated hydrogen peroxide 
production might be responsible for enhanced parasite killing 
[17], especially in view of our observations that circulating 
factors can enhance oxidative metabolism of eosinophils [21]. 
The demonstration that large amounts of hydrogen peroxide 
can be elicited after appropriate stimuli and that small amounts 
are continuously secreted are further support for the hypothesis 
that eosinophils play an in1portant effector role in parasitic 
infection. 
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